Kessler: FDA pre-emption is of no benefit to public
James G. Dickinson
May 01 2008
FDA pre-emption of "failure-to-warn" state lawsuits over drug risks does nothing to benefit the agency or the public and can ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.